X0306 4 2015-05-20 0 0001014739 BioScrip, Inc. BIOS 0001409751 Coliseum Capital Management, LLC METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902 1 0 1 0 0001430708 Shackelton Christopher S METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902 1 0 1 0 0001409585 Coliseum Capital, LLC METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902 1 0 1 0 0001356974 COLISEUM CAPITAL PARTNERS L P METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902 1 0 1 0 0001567187 Coliseum Capital Partners II, L.P. METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902 1 0 1 0 0001454123 Gray Adam METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD CT 06902 1 0 1 0 Phantom Stock 2015-05-20 4 A 0 10000 0.00 A Common Stock 10000 10000 I See Footnotes Each share of phantom stock is a market-based cash award which is the economic equivalent of one share of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of a share of Common Stock as of the vesting date, based on the closing market price of the Common Stock on such date. The shares of phantom stock vest on the business day immediately preceding the date of the Issuer's 2016 annual meeting of stockholders, provided that Christopher Shackelton ("Shackelton") continues to serve as a director of the Issuer as of such date. If unvested on the vesting date, the shares of phantom stock expire. The phantom stock was received by Shackelton in connection with his service as a member of the board of directors of the Issuer. Shackelton has agreed that all equity awards he receives for serving as a director of the Issuer shall be issued to Coliseum Capital Partners, L.P. ("CCP"). Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of (a) Coliseum Capital Management, LLC ("CCM"), the investment advisor to and a separate investment advisory account managed by CCM (the "Separate Account") and (b) Coliseum Capital, LLC ("CC"), the general partner of each of CCP and Coliseum Capital Partners II, L.P. ("CCP2") and may be deemed to have an indirect pecuniary interest in the shares held by CCP, CCP2, and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from CCP and CCP2. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein. Shackelton is a director of the Issuer. As a result, the following persons may be deemed directors by deputization of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended: Gray, CCM, CC, CCP, and CCP2. Coliseum Capital Management, LLC, By: /s/ Christopher Shackelton, Manager 2015-05-22 /s/ Christopher Shackelton 2015-05-22 Coliseum Capital, LLC, By: /s/ Christopher Shackelton, Manager 2015-05-22 Coliseum Capital Partners, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Christopher Shackelton, Manager 2015-05-22 Coliseum Capital Partners II, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Christopher Shackelton, Manager 2015-05-22 /s/ Adam Gray 2015-05-22